FindTrial
Sign In

"THE CLINICAL TRIAL TO STUDY THE EFFECT OF TWO DRUGS ADRAKAKHANDA AND HARIDRAKHANDA IN THE MANAGEMENT OF SHEETPITTA (URTICARIA)"

"THE CLINICAL STUDY OF ADRAKAKHANDA AND HARIDRAKHANDA IN THE MANAGEMENT OF SHEETPITTA W.S.R. URTICARIA"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/08/006073
Enrollment
34
Registered
2015-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SHEETPITTA

Interventions

Intervention1: Group-A Adrakakhanda: Orally 6 gram OD for 1 month Control Intervention1: GROUP-B HARIDRAKHANDA : 6 gram OD for 1 month

Sponsors

GOVT AKHANDANAND AYURVED COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients will be selected on the basis of classical sign and symptoms of SHEETPITTA described in ayurved classics like.... Varti Damshta Samsthana Shotha, Kandu, Toda, Vidaha, Mandala, Kshanikotpattivinash.

Exclusion criteria

Exclusion criteria: Disease like Giant urticaria, Angioedema, Diabetes mellitus, T.B., and other systemic disorder which leads fatal condition for patient.

Design outcomes

Primary

MeasureTime frame
All the signs and symptoms of Sheetpitta will be assigned score depending upone their severity to assess the effect of the drugs at the time of Before treatment and After treatment.Timepoint: 1 month—

Secondary

MeasureTime frame
NIlTimepoint: NIL—

Countries

India

Contacts

Public ContactMR DHARMESHKUMAR JAYANTILAL PATEL

GOVT AKHANDANAND AYURVED COLLEGE,AHMEDABAD

ashokpandya01@yahoo.com09879090959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026